🇺🇸 FDA
Pipeline program

Autologous differentiated myocyte transplantation

202602

Phase 1 mab active

Quick answer

Autologous differentiated myocyte transplantation for Metabolic Disease is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Metabolic Disease
Phase
Phase 1
Modality
mab
Status
active

Clinical trials